Scotiabank initiated coverage of Amgen (AMGN) with an Outperform rating and $385 price target
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMGN:
- QQQ ETF News, 11/12/2025
- Quantum Computing News: DARPA Picks 11 Startups, Quantinuum Unveils Helios, LG Bets on Pasqal
- Amgen announces results from Phase 3 VESALIUS-CV trial
- Amgen price target raised to $315 from $305 at Cantor Fitzgerald
- Amgen Stock Overvaluation Concerns Amid Mixed Future Guidance and Pipeline Delays